$16.19+$1.89 (+13.22%)in 1 year

As on 13 Nov 2026 at 02:29NYSE

52 Week Low: $9.2352 Week High: $17.48

Perrigo Share Price Today

Perrigo opened higher at $16.63, compared with its previous close of $16.55. In the last trading session, the stock traded between $16.04 and $16.76. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 5 years ago in Perrigo is now worth

$ 37.39

Resulting in a loss of

$ 62.61 (62.61%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Rating from 2 Analysts

Buy

50%

Hold

50%

Sell

Markets Today

Today's Change

$-0.36 (-2.18%)

Day High

$16.76

Day Low

$16.04

Day Open

$16.63

Prev Close

$16.55

Volume

9,28,342

1W Return

2.18%

1M Return

4.71%

3M Return

26.00%

6M Return

46.25%

1Y Return

13.22%

Fundamentals

Market Cap ($ Mn)

2,247

PE Ratio

PB Ratio

0.80

PEG Ratio

ROE

-34.14%

ROCE

-13.29%

EPS (TTM)

$-0.20

Investment Returns

1 Week

2.18%

1 Month

4.71%

3 Months

26.00%

6 Months

46.25%

9 Months

10.89%

Financials

Quarterly

All values in $ Mn

1.1K

Jun 25

1.0K

Sep 25

1.1K

Dec 25

969.2

Mar 26

1.0K

Jun 26

988.6

Sep 26

Updates

4Nov

Perrigo Q3 Results: Adjusted EPS $0.60 beats estimate, sales fall 5.18%

Perrigo reported adjusted EPS of $0.60, beating the $0.50 consensus estimate by 20%. Quarterly sales reached $989 million, exceeding estimates by 0.18%. Both EPS and sales declined year-over-year, with EPS down 25% and sales down 5.18%.

8 days ago

31Oct

Canaccord Genuity raises Perrigo price target to $19, maintains Buy

Canaccord Genuity maintains Buy rating on Perrigo. Price target raised from $17 to $19. Analyst Susan Anderson issued the rating update.

13 days ago

22Jul

Perrigo to release Q2 2026 financial results on August 5

Perrigo Company plc will release its second quarter 2026 financial results on Wednesday, August 5, 2026. A conference call hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will follow at 8:30 a.m. EST. The call will be available via webcast and phone, with a replay accessible until August 12, 2026.

3mo ago

9Jun

Perrigo appoints Albert A. Manzone interim CEO, reaffirms FY26 guidance

Perrigo Company plc appointed Albert A. Manzone as Interim President and CEO, succeeding Patrick Lockwood-Taylor, who resigned immediately. The Board has begun a search for a permanent successor. Perrigo reaffirmed its FY26 guidance, including All In net sales growth of (5.5)% to (1.5)% and All In adjusted EPS of $2.00 to $2.30.

5mo ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
L Eli Lilly	$1,437.29	+0.35%	$13,52,123.38M	39.43
J Johnson & Johnson	$280.41	-0.13%	$6,75,033.80M	31.06
A Abbvie	$294.98	+0.37%	$5,21,411.37M	72.17
M Merck & Co	$147.18	-0.59%	$3,62,834.91M	117.74
N Novartis AG	$160.32	-1.80%	$3,26,222.34M	23.23
A Astrazeneca	$185.48	-0.69%	$2,87,691.54M	24.32
A AMGEN	$468.11	+0.62%	$2,53,205.85M	26.86
G Gilead Sciences	$169.73	-0.67%	$2,10,522.74M	-
P Pfizer	$29.45	+0.31%	$1,67,860.70M	36.79
N Novo Nordisk	$41.09	+0.96%	$1,39,300.36M	11.15
B Bristol Myers Squibb	$62.91	+0.18%	$1,28,593.45M	14.67
S Sanofi	$48.43	+0.41%	$1,16,984.89M	23.63